Meta Information
ID:semax
Name:
Schema Version:AIM-2.0
Interactions
Target id:
/class/maois
Target name:
Monoamine Oxidase Inhibitors (MAOIs)
Severity:
major
Interaction type:
adverse
Nature:
absolute
Temporal spacing:
null
Description:
Semax can increase the turnover of monoamine neurotransmitters like dopamine and serotonin; co-administration with MAOIs could theoretically lead to a dangerous hypertensive crisis or serotonin syndrome.
Actionable advice:
Avoid using Semax completely if you are taking any MAOI medication.
Target id:
/intervention/intranasal-medications
Target name:
Other Intranasal Sprays
Severity:
major
Interaction type:
diminishing
Nature:
temporal
Temporal spacing:
Hours before target:
0.5
Hours after target:
0.5
Description:
Using other nasal sprays (like decongestants or corticosteroids) close to Semax administration can wash away the peptide or interfere with its absorption through the nasal mucosa.
Actionable advice:
Separate administration of Semax and any other nasal spray by at least 30 minutes.
Target id:
/condition/pregnancy
Target name:
Pregnancy
Severity:
major
Interaction type:
adverse
Nature:
absolute
Temporal spacing:
null
Description:
The safety of Semax during pregnancy has not been established, and its effects on fetal development are unknown.
Actionable advice:
Do not use Semax if you are pregnant.
Target id:
/condition/lactation
Target name:
Breastfeeding (Lactation)
Severity:
major
Interaction type:
adverse
Nature:
absolute
Temporal spacing:
null
Description:
It is not known if Semax is excreted in breast milk or what its effects might be on a nursing infant.
Actionable advice:
Do not use Semax while breastfeeding.
Target id:
/class/stimulants
Target name:
Stimulant Medications
Severity:
moderate
Interaction type:
adverse
Nature:
absolute
Temporal spacing:
null
Description:
Both Semax and stimulant medications (e.g., amphetamines, methylphenidate) increase dopaminergic activity, which can lead to overstimulation, anxiety, restlessness, and increased cardiovascular strain.
Actionable advice:
Avoid co-administration or use with extreme caution under medical supervision.
Target id:
/class/serotonergic-agents
Target name:
Serotonergic Medications (SSRIs, SNRIs, etc.)
Severity:
moderate
Interaction type:
adverse
Nature:
absolute
Temporal spacing:
null
Description:
Semax may modulate serotonin systems, and combining it with other serotonergic drugs could theoretically increase the risk of serotonin syndrome, a potentially serious condition.
Actionable advice:
Use with caution and monitor for symptoms like agitation, confusion, or rapid heart rate.
Target id:
/class/dopaminergic-agents
Target name:
Dopaminergic Medications (e.g., Levodopa)
Severity:
moderate
Interaction type:
synergistic
Nature:
absolute
Temporal spacing:
null
Description:
Semax can enhance the effects of dopaminergic agents used for conditions like Parkinson's disease, potentially requiring dose adjustments to avoid side effects.
Actionable advice:
Consult your physician before combining; dose adjustments of the dopaminergic agent may be necessary.
Target id:
/condition/seizure-disorder
Target name:
Seizure Disorder / Epilepsy
Severity:
moderate
Interaction type:
adverse
Nature:
absolute
Temporal spacing:
null
Description:
While not definitively established, some nootropic agents may lower the seizure threshold, posing a theoretical risk for individuals with a history of seizures.
Actionable advice:
Use with extreme caution and only under the guidance of a neurologist.
Target id:
/condition/nasal-congestion
Target name:
Nasal Congestion (e.g., from a cold)
Severity:
moderate
Interaction type:
diminishing
Nature:
absolute
Temporal spacing:
null
Description:
Impaired airflow and inflammation of the nasal mucosa due to a cold, allergies, or sinusitis will significantly reduce the absorption and effectiveness of intranasal Semax.
Actionable advice:
Wait until nasal passages are clear before using Semax for optimal effect.
Target id:
/intervention/alcohol
Target name:
Alcohol
Severity:
moderate
Interaction type:
diminishing
Nature:
absolute
Temporal spacing:
null
Description:
Alcohol is a neurotoxin and CNS depressant that counteracts the neuroprotective and cognitive-enhancing goals of Semax therapy.
Actionable advice:
Avoid or minimize alcohol consumption to maximize the benefits of Semax.
Target id:
/class/anticoagulants-antiplatelets
Target name:
Anticoagulants and Antiplatelets
Severity:
minor
Interaction type:
adverse
Nature:
absolute
Temporal spacing:
null
Description:
Some ACTH fragments have shown effects on the coagulation system in preliminary research; there is a theoretical risk of altered bleeding time when combined with these medications.
Actionable advice:
Use with caution and monitor for any signs of unusual bruising or bleeding.
Target id:
/class/antihypertensives
Target name:
Antihypertensive Medications
Severity:
minor
Interaction type:
adverse
Nature:
absolute
Temporal spacing:
null
Description:
As an ACTH analogue, Semax has a theoretical potential to slightly increase blood pressure, which could minimally counteract the effects of blood pressure-lowering medications.
Actionable advice:
Monitor blood pressure regularly if combining Semax with antihypertensive drugs.
Target id:
/intervention/cerebrolysin
Target name:
Cerebrolysin
Severity:
minor
Interaction type:
synergistic
Nature:
absolute
Temporal spacing:
null
Description:
Both Semax and Cerebrolysin are peptide-based nootropics that promote neurotrophic factors like BDNF, potentially leading to additive or synergistic cognitive benefits.
Actionable advice:
May be used together, but start with lower doses of each to assess tolerance.
Target id:
/intervention/exercise
Target name:
Exercise
Severity:
minor
Interaction type:
synergistic
Nature:
temporal
Temporal spacing:
Hours before target:
1
Hours after target:
null
Description:
Semax increases BDNF levels, and exercise is a potent natural stimulus for BDNF production. Using Semax before a workout may enhance focus and the neuroplastic benefits of the exercise.
Actionable advice:
Consider administering Semax 30-60 minutes before exercise for potential synergistic effects.